ACTRN12614000507684招募中2 期
Randomised phase 2 trial of pre-surgical aromatase inhibitor, combined with non-steroidal anti inflammatory drug treatment or no additional treatment, in post-menopausal women with early stage operable breast cancer, to determine anti-proliferative response to aromatase inhibitor and effect of both agents on immune cell composition.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 50 Years 至 o limit（—）
- 性别
- Female
入选标准
- •ER positive, stage 1-2 breast cancer, post-menopausal, no prior therapy
排除标准
- •not post-menopausal, prior breast cancer, other illnesses,
研究者
相似试验
已完成
不适用
An investigation into the Benefits of Lavender Oil and Hand Massage as Complementary Therapies on Disruptive Behaviour in People with Dementia.ACTRN12612000917831Griffith University75
进行中（未招募）
1 期
PARAGON - Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological neoplasmsPatients with potentially hormone responsive recurrent or metastatic gynaecological cancers from following subgroups:A - Epithelial ovarian cancer, primary peritoneal cancers and cancers of the fallopian tubeB- Endometrial cancerC- Endometrial Stromal SarcomasD- Miscellaneous SarcomasE- Granulosa Cell Tumours and other Sex Tumours * UK sites will only enter patients to subgroups B-E *MedDRA version: 14.1Level: LLTClassification code 10026310Term: Malignant neoplasm of ovarySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10014760Term: Endometrial neoplasm malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-000501-52-GBGreater Glasgow and Clyde350
已完成
不适用
Phase II trial of ethinylestradiol for aromatase inhibitor-resistant postmenopausal advanced/recurrent breast cancer patientsaromatase inhibitor-resistant advanced/recurrent breast cancerJPRN-UMIN000015698Keio University School of Medicine40
进行中（未招募）
2 期
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)ER Positive Breast CancerBreast CancerNCT04568616Dartmouth-Hitchcock Medical Center178
已完成
不适用
A randomised trial of sequential aromatase inhibitors (AI) in postmenopausal women with locally advanced or metastatic breast cancerCancerBreast cancerISRCTN99515843International Collaborative Cancer Group (ICGG) (UK)